Market cap
₹67 Cr
Revenue (TTM)
₹181 Cr
P/E Ratio
15.4
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
5.2 %
-
ROCE
6.9 %
-
Industry P/E
34.64
-
EV/EBITDA
9.7
-
Debt to Equity
0
-
Book Value
₹5.3
-
EPS
₹0.3
-
Face value
2
-
Shares outstanding
172,243,598
10 Years Aggregate
CFO
₹-5.48 Cr
EBITDA
₹17.01 Cr
Net Profit
₹9.60 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ajooni Biotech
| -11.1 | -11.3 | -13.9 | -32.3 | -2.6 | -12.7 | -- |
|
BSE FMCG
| -10.3 | -4.6 | 0.5 | -11.8 | -0.1 | 6.3 | 8.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Ajooni Biotech
| -47.1 | 33.5 | 2.4 | -50.5 | 164.6 | 251.6 | -65.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ajooni Biotech
|
3.8 | 66.7 | 180.5 | 5.0 | 3.4 | 5.5 | 15.4 | 0.7 |
| 187.3 | 24,440.5 | 74,730.7 | 990.4 | 2.3 | 10.4 | 23.5 | 2.3 | |
| 674.7 | 16,900.9 | 2,993.9 | 254.4 | 10.5 | 16.8 | 65.4 | 10.5 | |
| 563.6 | 10,827.0 | 10,232.7 | 405.0 | 6.2 | 25.9 | 22.9 | 5.3 | |
| 912.2 | 20,381.5 | 9,808.5 | 386.3 | 6.6 | 20.3 | 57.2 | 10.5 | |
| 185.0 | 594.9 | 1,680.5 | 84.0 | 6.0 | 24 | 7.1 | 1.7 | |
| 38.2 | 142.3 | 78.4 | 3.9 | 6.1 | 6.6 | 36.9 | 2.4 | |
| 15.5 | 7.8 | 10.5 | -0.1 | -11.1 | -0.4 | -- | 0.5 | |
| 28.8 | 39.0 | 2.4 | 0.3 | 16.6 | -- | 121.9 | 1.7 | |
| 21.0 | 8.6 | 0.0 | 0.1 | -- | 1.3 | 126.6 | 1.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Ajooni Biotech
Ajooni Biotech Limited manufactures and sells cattle feed in India. Its portfolio includes cattle feed chips, camel feed, cotton oil cakes, mustard oil cakes, and feed supplements. Ajooni Biotech Limited was incorporated in 2010 and is based in... Mohali, India. Read more
-
Incorporated
2010
-
Chairman
--
-
Managing Director
Jasjot Singh
-
Headquarters
Mohali, Punjab
-
Website
Looking for more details about Ajooni Biotech Ltd.’s IPO? Explore our IPO Details page.
Announcements
View AnnouncementsFAQs for Ajooni Biotech
What is the current share price of Ajooni Biotech Ltd Today?
The share price of Ajooni Biotech Ltd is ₹3.83 (NSE) as of 12-Jun-2026 13:09 IST. Ajooni Biotech Ltd has given a return of -2.59% in the last 3 years.
What is the current PB & PE ratio of Ajooni Biotech Ltd?
The P/E ratio of Ajooni Biotech Ltd is 15.42 times as on 12-Jun-2026, a 55 discount to its peers’ median range of 34.64 times.
The P/B ratio of Ajooni Biotech Ltd is 0.73 times as on 12-Jun-2026, a 57 discount to its peers’ median range of 1.68 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
28.60
|
1.10
|
|
2024
|
21.09
|
1.07
|
|
2023
|
27.12
|
0.73
|
|
2022
|
9.98
|
3.20
|
|
2021
|
14.38
|
1.52
|
What is the 52 Week High and Low of Ajooni Biotech Ltd?
The 52-week high and low of Ajooni Biotech Ltd are Rs 6.60 and Rs 3.40 as of 12-Jun-2026.
What is the market cap of Ajooni Biotech Ltd?
Ajooni Biotech Ltd has a market capitalisation of ₹ 67 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Ajooni Biotech Ltd?
Before investing in Ajooni Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.